Peptides DB
Research-centric peptide and protocol reference hub
Study 17 of 17Oxytocin literaturebiorxiv-preprint · Observational2026

Social and neuroendocrine phenotypes reprogrammed by endocrine-disrupting chemicals can be mitigated by Limosilactobacillus reuteri modulation of the gut microbiome-thyroid-oxytocin axis

Limosilactobacillus reuteri supplementation may help mitigate some behavioral deficits associated with PBDE exposure in mice, but the relevance to human health is unclear.

Read at biorxiv-preprintAdd to compare

Where it sits

this study against the rest of the oxytocin corpus
1
Preclinical
10
Observational · this one
0
Open-label
4
Randomised
2
Reviews

Summary and findings

This study investigated the effects of Limosilactobacillus reuteri (LR) supplementation on socioemotional behavior in C57BL/6N mouse offspring exposed to polybrominated diphenyl ethers (PBDEs). Offspring were supplemented with LR during development, and various behavioral and biological outcomes were measured. The study found that LR treatment normalized certain behavioral deficits and altered thyroid hormone signaling in a sex-dependent manner.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
LR treatment increased plasma total thyroxine in DE-71 and plasma OXT in VEH/CON dams.2026

Abstract

The authors’ words, as biorxiv-preprint supplied them

<h4>Introduction: </h4> Environmental factors are increasingly implicated in the etiology of autism spectrum disorder (ASD). Polybrominated diphenyl ethers (PBDEs) are anthropogenic toxicants added as flame retardants to consumer products that have become ubiquitous environmental contaminants and disrupt thyroid hormone (TH) and neuroendocrine systems. We have previously shown that developmental PBDE exposure produces ASD-like traits with involvement of oxytocin (OXT)-thyroid hormone signaling. Limosilactobacillus reuteri (LR), a widely used probiotic bacterium, has been shown to improve social functioning and increase TH and OXT levels in murine models. Therefore, we tested the hypothesis that LR supplementation (LR) prevents PBDE-induced deficits in socioemotional behavior with concomitant modulation of TH signaling genes on hypothalamic OXT neurons. <h4>Methods:</h4> C57BL/6N mouse offspring were exposed to a commercial penta-mixture of PBDE congeners, DE-71, at an environmentally realistic concentration, 0.1 mg/kg/d (DE-71), or to corn oil vehicle (VEH/CON) via their mothers during gestation and lactation. Offspring received supplementation with LR ATCC PTA 6475 (107-108 CFU/mL, po) indirectly via the dam or continuation directly through adulthood. Unsupplemented controls were given saline. <h4>Results:</h4> Fecal microbiome analysis in offspring confirmed colonization of LR at postnatal day (P) 40 and depletion by P104. LR treatment increased plasma total thyroxine in DE-71 and plasma OXT in VEH/CON dams. In DE-71 offspring of both sexes, LR normalized deficient scores on social novelty preference and emotional recognition in adult females and males and deficient long-term social recognition memory (SRM) in adult DE-71 females; DE-71 males were normal. Reduced olfactory dishabituation between two social odors may partly explain the compromised socioemotional behavior produced by DE-71 in an LR-dependent manner. Multiplex RNA in situ hybridization performed on immunoreactive OXT-ergic neurons in the paraventricular hypothalamic nucleus (PVH) revealed significant upregulation of TH transporter monocarboxylate transporter 8 (Mct8) and downregulation of iodothyronine deiodinase 3 (Dio3) in DE-71 relative to VEH/CON females. This toxicant-induced reprogramming was prevented by probiotic treatment. DE-71 males expressed reduction in Mct8 and Dio3 transcripts on OXT-ergic neurons with minimal LR protection. In the female supraoptic nucleus (SON), Mct8 and Dio3 were downregulated by DE-71 and normalized in DE-71+LR; there were no group effects on transcript levels in male SON. Results of fecal 16S rRNA sequencing indicated reduced α-diversity and altered β-diversity in the gut bacterial community of female but not male DE-71 exposed offspring; most changes were correctable by LR. Alterations in taxa-level abundance caused by DE-71 and reversed by LR were observed in both sexes. These involved Bifidobacterium, Coprococcus, Desulfovibrio, Oscillospira, and Peptococcaceae in females and Desulfovibrionaceae, Rikenella, and Turicibacter in males. Exposed dams showed no detriment in α- and β-diversity while showing reduced abundance of several Firmicutes and Proteobacteria taxa that could be rescued by LR. The relative abundance of Lactobacillus was upregulated in DE-71 males and DE-71+LR males and dams. <h4>Conclusions:</h4> These results indicate that developmental probiotic supplementation effectively mitigated organohalogen-induced ASD-like deficits in socioemotional behavior and partially corrected dysbiosis of gut bacterial communities in exposed offspring of both sexes. Concomitantly, PBDEs altered the expression of TH regulatory genes Mct8 and Dio3 in PVH OXT neurons in a sex-dependent manner, suggesting that TH regulation of OXT neuroendocrine cells may modulate the emergence of toxicant-induced ASD-relevant behavior. While LR reinstated normal behavioral outcomes in PBDE-exposed offspring of both sexes, coincident normalization of hypothalamic TH signaling transcripts occurred more broadly in females, indicating the existence of unique parallel processes influencing the preventive effects of LR on ASD-relevant behavioral deficits in both sexes.

Background

The paper addresses the interaction between endocrine-disrupting chemicals and the gut microbiome, specifically focusing on how these factors may influence the thyroid and oxytocin levels. Previous research has indicated that the gut microbiome can affect neuroendocrine functions, but the specific mechanisms remain unclear. This study aims to explore whether modulation of the gut microbiome can mitigate adverse effects caused by these chemicals.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.

Elsewhere in the Oxytocin corpus

BCeasing oxytocin in the active phase of the first stage of induced labours: A prospective audit at a tertiary hospitalbiorxiv-preprint · 2026 · Caesarean delivery occurred in 29% of women before and 28% after policy implementation (p=0.77).HumanAEASing Oxytocin in Early Labour - OUTcomes for Mothers and Babies (EASE-OUT): a feasibility randomised controlled trialbiorxiv-preprint · 2026 · Randomised participants represented 9.2% of all births during active recruitment.HumanBLocal application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.europepmc · 2026 · Not reported in abstract.HumanBVaginal trial outcomes and emergency cesarean section factors among women with different classifications of hypertensive disorders of pregnancy.europepmc · 2026 · Success rate of vaginal delivery ranged from 85.1% to 90.8%.HumanBMidwives' lived experiences of obstetric violence: a hermeneutic phenomenological study.europepmc · 2026HumanAEffect of oral calcium carbonate on uterine contractility: a pilot randomised controlled trial.europepmc · 2026 · No statistically significant difference in baseline MVUs between groups (p=0.1825).Human